|

pp65 RNA LP (DP1) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Florida1

Indications

  • Recurrent Pulmonary Osteosarcoma1
  • Recurrent High Grade Glioma1
  • Lung Cancer1
  • Cancer1

Gainesville, Florida1 trial

RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors

UF Health

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.